Every Dose Paid For
Should Be Delivered
Specialty medications represent some of healthcare's highest-cost therapies. Healthcare organizations continually evaluate opportunities to maximize medication utilization, reduce avoidable waste, and support responsible use of healthcare resources.
Biologics, immunoglobulins, oncology therapies, and other specialty medications represent significant healthcare investments. As utilization continues to grow, healthcare organizations increasingly evaluate opportunities to improve medication utilization, operational efficiency, and reduction of avoidable waste.
High-Value Therapies Deserve High-Value Preparation
High-Cost Therapies
Biologics, immunoglobulins, oncology therapies, and other specialty medications represent some of healthcare's highest-cost treatments.
Medication Utilization
Healthcare organizations continually evaluate opportunities to maximize utilization of prescribed therapies.
Avoidable Waste
Even small amounts of residual medication can become meaningful when multiplied across large patient populations and treatment volumes.
Value-Based Care
Payers and providers increasingly focus on approaches that support quality outcomes while improving healthcare resource utilization.
SEE I2F IN ACTION
See how introducing filtered air directly into the medication container headspace may support more consistent medication preparation while reducing the need for repeated container manipulation.
🔹 I2F Preparation Approach
Filtered air enters directly into the container headspace.
Fluid remains visibly calmer during preparation.
Designed to support more controlled preparation workflows
🔹 Traditional Preparation Approach
Air moves through the medication solution
Visible foaming and bubble formation may occur during preparation.
May require additional container manipulation
Why This Matters
Small Differences Become Meaningful at Scale
Even small amounts of residual medication may become meaningful when multiplied across thousands of annual treatments. Healthcare organizations continually evaluate opportunities to maximize medication utilization, improve preparation consistency, and reduce avoidable waste.
Medication Utilization | Operational Efficiency | Preparation Consistency | Healthcare Value
Clinical & Economic Evaluation of I2F
Explore the clinical, operational, and economic considerations surrounding biologic medication preparation, medication utilization, avoidable waste, and healthcare resource stewardship.
Developed by clinicians, pharmacists, healthcare executives, and subject matter experts with experience in infusion therapy, biologics, pharmacy operations, and healthcare administration.
What's Included
✓ Clinical rationale
✓ Economic framework
✓ Literature review
✓ Published references
✓ Value-based care considerations
✓ Implementation considerations
Key Topics Covered
✓ Protein aggregation and immunogenicity
✓ Medication utilization
✓ Residual medication loss
✓ Workflow efficiency
✓ Healthcare resource utilization
✓ Value-based care alignment
Ready to Learn More?
We welcome conversations with healthcare organizations, payers, pharmacy leaders, and clinical stakeholders interested in medication utilization, biologic preparation, and healthcare resource optimization.